temozolomide has been researched along with Bilirubinemia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide is an alkylating agent used along with concurrent radiation therapy in the treatment of glioblastoma." | 3.83 | Temozolomide-induced biliary ductopenia: a case report. ( Balakrishnan, A; Jaglal, M; Ledford, R, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balakrishnan, A | 1 |
| Ledford, R | 1 |
| Jaglal, M | 1 |
1 other study available for temozolomide and Bilirubinemia
| Article | Year |
|---|---|
Temozolomide-induced biliary ductopenia: a case report.
Topics: Antineoplastic Agents, Alkylating; Bile Duct Diseases; Bile Ducts, Intrahepatic; Chemoradiotherapy; | 2016 |